CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash flows from operating activities:
Net income (loss)	$ 75,564	$ (313,282)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	105,982	97,065
Amortization of debt discount on notes payable	159,791	317,843
Amortization of right of use assets	341,384	687,226
Gain on debt extinguishment	(754,000)	0
Share-based payment compensation	9,168	7,570
Provision for (recovery of) returns and doubtful accounts	0	(81,244)
Deferred income taxes (benefit)	7,139	0
Changes in operating assets and liabilities:
Accounts receivable	667,748	1,628,983
Prepaid expenses and other current assets	302,404	277,525
Contract assets	38,016	399,320
Inventory	0	14,571
Other assets	(269)	(7,160)
Accounts payable	102,950	(605,831)
Accrued expenses and other long-term liabilities	(551,245)	(298,558)
Operating lease liabilities	(468,821)	(810,426)
Deferred revenue	(381,096)	(1,988,705)
Net cash provided by (used in) operating activities	(345,285)	(675,103)
Cash flows from investing activities:
Purchases of property and equipment	(60,444)	0
Security deposits	739,484	0
Purchase of intangible assets	(10,436)	(35,655)
Net cash provided by (used in) investing activities	668,604	(35,655)
Cash flows from financing activities:
Proceeds from public offering, net of underwriting discounts paid	3,095,203	0
Payments of offering costs	(265,252)	0
Proceeds from issuance of PPP loan	0	754,000
Payments of short-term debt	(1,334,058)	0
Net cash provided by (used in) financing activities	1,495,893	754,000
Effect of exchange rate changes on cash and cash equivalents	1,732	(4,057)
Net increase (decrease) in cash and cash equivalents	1,820,944	39,185
Cash and cash equivalents, beginning of period	1,920,656	1,475,166
Cash and cash equivalents, end of period	3,741,600	1,514,351
Supplemental disclosures:
Cash paid for interest	86,860	110,708
Non-cash investing and financing activities:
Accrual of deferred offering costs	92,181	0
Undistributed Series A redeemable convertible preferred stock dividends	560,096	546,355
Accretion of Series A redeemable convertible preferred stock	$ 272,297	$ 191,231